Home Cart Sign in  
Chemical Structure| 31083-55-3 Chemical Structure| 31083-55-3

Structure of PRT4165
CAS No.: 31083-55-3

Chemical Structure| 31083-55-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PRT4165, an inhibitor of bim1 and ring1A, could block PRC1 (Polycomb-repressive complex 1)-mediated H2A ubiquitylation.

Synonyms: NSC600157

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PRT4165

CAS No. :31083-55-3
Formula : C15H9NO2
M.W : 235.24
SMILES Code : O=C1/C(C(C2=C1C=CC=C2)=O)=C/C3=CC=CN=C3
Synonyms :
NSC600157
MDL No. :MFCD00435709
InChI Key :OMHZFEWYVFWVLI-UHFFFAOYSA-N
Pubchem ID :207893

Safety of PRT4165

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317
Precautionary Statements:P280

Isoform Comparison

Biological Activity

Target
  • E3 Ligase

    Bmi1/Ring1A, IC50:3.9 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
U2OS cells 50 μM 60 minutes PRT4165 inhibits PRC1-mediated H2A ubiquitylation PMC3772243

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Myocardial ischemia/reperfusion injury (MI/RI) model Caudal vein injection 4 mg/kg and 8 mg/kg Once daily for three days PRT@PPMP significantly restored LVFS and LVEF, reduced the area of myocardial infarction, decreased levels of ROS, MDA, and ptgs2, and improved mitochondrial function. PMC10730859

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.25mL

0.85mL

0.43mL

21.25mL

4.25mL

2.13mL

42.51mL

8.50mL

4.25mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories